Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPATINIB DITOSYLATE for Brain neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where LAPATINIB DITOSYLATE was used for Brain neoplasm.

Most Reported Side Effects for LAPATINIB DITOSYLATE

Side Effect Reports % Deaths Hosp.
Diarrhoea 893 22.6% 82 181
Death 665 16.8% 664 22
Nausea 317 8.0% 26 75
Fatigue 301 7.6% 28 72
Vomiting 259 6.6% 24 97
Rash 249 6.3% 12 36
Drug ineffective 183 4.6% 14 16
Malignant neoplasm progression 183 4.6% 55 47
Off label use 141 3.6% 3 42
Disease progression 137 3.5% 35 22
Palmar-plantar erythrodysaesthesia syndrome 135 3.4% 16 40
Metastases to central nervous system 132 3.3% 27 50
Decreased appetite 119 3.0% 20 35
Dry skin 119 3.0% 3 12
Asthenia 113 2.9% 20 49

Other Indications for LAPATINIB DITOSYLATE

Breast cancer (1,219) Product used for unknown indication (864) Breast cancer metastatic (531) Breast cancer female (503) Her2 positive breast cancer (129) Neoplasm malignant (112) Her-2 positive breast cancer (62) Brain neoplasm malignant (42) Metastatic neoplasm (42) Metastases to bone (25)

Other Drugs Used for Brain neoplasm

TEMOZOLOMIDE (286) BEVACIZUMAB (166) PROCARBAZINE (142) ETOPOSIDE (121) CARBOPLATIN (103) VINCRISTINE (93) CYCLOPHOSPHAMIDE (72) CISPLATIN (67) TRAMETINIB DIMETHYL SULFOXIDE (55) BEVACIZUMAB-AWWB (50)

Related Pages

LAPATINIB DITOSYLATE Full Profile All Brain neoplasm Drugs LAPATINIB DITOSYLATE Demographics LAPATINIB DITOSYLATE Timeline